Regulation of IL (Interleukin)-33 Production in Endothelial Cells Via Kinase Activation and Fas/CD95 Upregulation

Catherine Duez,Barbara Gross,Philippe Marquillies,Valerie Ledroit,Bernhard Ryffel,Corine Glineur

DOI: https://doi.org/10.1161/atvbaha.120.314832

2020-01-01

Arteriosclerosis Thrombosis and Vascular Biology

Abstract:Objective:The occurrence of new blood vessel formation in the lungs of asthmatic patients suggests a critical role for airway endothelial cells (ECs) in the disease. IL-33 (Interleukin-33)—a cytokine abundantly expressed in human lung ECs—recently emerged as a key factor in the development of allergic diseases, including asthma. In the present study, we evaluated whether mouse and human ECs exposed to the commonDermatophagoides farinaeallergen produce IL-33 and characterized the activated signaling pathways.Approach and Results:Mouse primary lung ECs were exposed in vitro toD farinaeextract or rmIL-33 (recombinant murine IL-33). BothD farinaeand rmIL-33 inducedIl-33transcription without increasing the IL-33 production and upregulated the expression of its receptor, as well as genes involved in angiogenesis and the regulation of immune responses. In particular,D farinaeand rmIL-33 upregulatedFas/Cd95transcript level, yet without promoting apoptosis. Inhibition of caspases involved in the Fas signaling pathway, increased IL-33 protein level in ECs, suggesting that Fas may decrease IL-33 level through caspase-8-dependent mechanisms. Our data also showed that the NF-κB (nuclear factor-κB), PI3K/Akt, and Wnt/β-catenin pathways regulateIl-33transcription in both mouse and human primary ECs.Conclusions:Herein, we described a new mechanism involved in the control of IL-33 production in lung ECs exposed to allergens.